Human SARS-CoV-2 IgA antibody ELISA Kit
Key features and details
- 产品描述:
- 反应物种:
- 应用:
- 靶点名称:
- 偶联标记:
- 偶联标记说明:
- 灵敏度:
- 检测范围:
- 样品类型:
-
Brand:
CAT.NO. : ARG83054
US＄ Please choose
US＄ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整，请以品牌方官网实时更新的价格为准，以确保准确性。
Product Details
概述
| 产品描述 | ARG83054 Human SARS-CoV-2 IgA antibody ELISA Kit is an enzyme immunoassay kit for the qualitative of SARS-CoV-2 IgA antibody in Human serum and plasma (EDTA, heparin, citrate) |
|---|---|
| 反应物种 | Hu |
| 应用 | ELISA |
| 靶点名称 | Human SARS-CoV-2 IgA |
| 偶联标记 | HRP |
| 偶联标记说明 | Substrate: TMB and read at 450 nm. |
| 灵敏度 | diagn. 100 % |
| 检测范围 | Cut - off |
| 样品类型 | serum, plasma (citrate, heparin) |
| 样本量 | 100 µl |
| 精确 | Intra-Assay CV: less than 8% Inter-Assay CV: less than 7% |
| 別名 | SARS-CoV |
应用说明
| 检测时间 | ~2 hour |
|---|
属性
| 形式 | 96 well |
|---|---|
| 存放说明 | Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components. |
| 注意事项 | For laboratory research only, not for drug, diagnostic or other use. |
生物信息
| 背景介绍 | Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19 (coronavirus disease 2019), the respiratory illness responsible for the ongoing COVID-19 pandemic. The virus previously had a provisional name, 2019 novel coronavirus (2019-nCoV), and has also been called the human coronavirus 2019 (HCoV-19 or hCoV-19). First identified in the city of Wuhan, Hubei, China, the World Health Organization declared the outbreak a public health emergency of international concern on January 30, 2020, and a pandemic on March 11, 2020. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans. |
|---|---|
| 产品亮点 | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Anti-Human IgG secondary antibodies; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 Exploring Antiviral Immune Response |
New Products
